XML 28 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 27,884 $ 46,506
Short-term investments, at amortized cost 126,598 121,782
Accounts receivable, net 4,682 5,778
Inventory 8,914 12,229
Prepaid expenses and other current assets 3,606 3,899
Total current assets 171,684 190,194
Investments, non-current, at amortized cost 35,781 42,938
Property and equipment, net 19,707 23,513
Right-of-use asset - operating leases 10,766 11,241
Other assets 1,532 388
Total assets 239,470 268,274
Current liabilities:    
Accounts payable 1,358 743
Accrued expenses and other 8,302 11,269
Operating lease liability, current 864 774
Deferred revenue, current portion 5,251 5,069
Total current liabilities 15,775 17,855
Operating lease liability, net of current portion 17,170 17,969
Other liabilities 274 283
Total liabilities 33,219 36,107
Commitments and contingencies (Note 8)
Stockholders' equity    
Preferred stock, $0.01 par value; 5,000,000 shares authorized and no shares issued and outstanding at December 31, 2024 and December 31, 2023
Common stock, $0.01 par value; 400,000,000 shares authorized, 105,711,093 and 103,961,670 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 1,057 1,040
Additional paid-in capital 422,047 406,925
Accumulated deficit (216,853) (175,798)
Total stockholders' equity 206,251 232,167
Total liabilities and stockholders' equity $ 239,470 $ 268,274